methyldopa has been researched along with Bipolar Disorder in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Johnson, JM | 1 |
Luchins, D | 1 |
Byrd, GJ | 1 |
Holzgang, AJ; Labbate, LA | 1 |
Yassa, R | 1 |
Brodie, HK; Bunney, WE; Goodwin, FK; Murphy, DL | 1 |
Klempel, K | 1 |
Greaney, JF; Klerman, GL; Mosher, LR | 1 |
Kariya, T; Kobayashi, K; Kobayashi, T; Nagao, Y; Takahashi, R; Takamizawa, M; Toru, M; Tsuchiya, K | 1 |
2 review(s) available for methyldopa and Bipolar Disorder
Article | Year |
---|---|
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan | 1976 |
4 trial(s) available for methyldopa and Bipolar Disorder
Article | Year |
---|---|
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; Clonidine; Depressive Disorder; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; Humans; Male; Mental Disorders; Methyldopa; Metoprolol; Migraine Disorders; Propranolol; Reserpine; Schizophrenia; Substance Withdrawal Syndrome | 1984 |
Biogenic amines and affective disorders. A critical analysis.
Topics: 5-Hydroxytryptophan; Affective Symptoms; Antidepressive Agents, Tricyclic; Biogenic Amines; Bipolar Disorder; Brain Chemistry; Clinical Trials as Topic; Depression; Electroconvulsive Therapy; Fenclonine; Fusaric Acid; Humans; Levodopa; Lithium; Methyldopa; Methyltyrosines; Methysergide; Monoamine Oxidase Inhibitors; Phenylketonurias; Reserpine; Tryptophan | 1976 |
Regular induction of hypomania by L-dopa in "bipolar" manic-depressive patients.
Topics: Antidepressive Agents; Bipolar Disorder; Catecholamines; Clinical Trials as Topic; Dihydroxyphenylalanine; Dopamine; Euphoria; Female; Humans; Hydrazines; Male; Methyldopa; Methyltyrosines; Middle Aged; Phenylacetates; Placebos; Psychomotor Disorders; Sleep, REM; Stereoisomerism; Visual Cortex | 1971 |
A clinical trial of alpha-methyldopa in elated states.
Topics: Adult; Bipolar Disorder; Clinical Trials as Topic; Humans; Hypotension; Male; Methyldopa; Middle Aged | 1966 |
5 other study(ies) available for methyldopa and Bipolar Disorder
Article | Year |
---|---|
Letter: Methyldopa and lithium carbonate: suspected interaction.
Topics: Bipolar Disorder; Carbonates; Drug Interactions; Female; Humans; Hypertension; Lithium; Methyldopa; Middle Aged | 1975 |
Manic syndrome after discontinuation of methyldopa.
Topics: Bipolar Disorder; Humans; Hypertension; Male; Methyldopa; Middle Aged; Substance Withdrawal Syndrome | 1989 |
Lithium-methyldopa interaction.
Topics: Aged; Bipolar Disorder; Cognition Disorders; Confusion; Drug Interactions; Female; Humans; Hypertension; Lithium; Lithium Carbonate; Methyldopa; Tremor | 1986 |
[Partial neuronal denervation as treatment principle of affective disorders. A preliminary report].
Topics: Adult; Aged; Amitriptyline; Bipolar Disorder; Brain; Catecholamines; Depression; Female; Humans; Male; Methyldopa; Middle Aged; Models, Neurological; Neurons; Remission, Spontaneous; Synaptic Transmission | 1974 |
Catecholamine metabolism of manic-depressive illness.
Topics: Antidepressive Agents; Bipolar Disorder; Calcium; Catecholamines; Creatinine; Disulfiram; Dopamine; Epinephrine; Humans; Hydroxyindoleacetic Acid; Imipramine; Male; Methyldopa; Middle Aged; Norepinephrine; Phenylacetates; Psychiatric Status Rating Scales; Vanilmandelic Acid | 1968 |